Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guava Technologies was a life science instrumentation company that pioneered the development of microcapillary flow cytometry systems. Founded in 1998 and headquartered in Hayward, California, the company focused on making cell analysis more accessible by creating compact, easy-to-use benchtop systems that required significantly less sample and sheath fluid than traditional flow cytometers. Their flagship products, including the Guava Personal Cell Analysis (PCA) and EasyCyte systems, enabled researchers to perform complex assays such as cell counting, viability, and apoptosis at their own lab benches. The company's innovative technology was widely adopted in drug discovery, toxicology, and basic research. In 2009, Guava Technologies was acquired by Millipore Corporation for approximately $22.6 million.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guava Technologies.